Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
PLoS One ; 9(9): e107265, 2014.
Article in English | MEDLINE | ID: mdl-25216251

ABSTRACT

Non-alcoholic fatty liver disease is prevalent in human obesity and type 2 diabetes, and is characterized by increases in both hepatic triglyceride accumulation (denoted as steatosis) and expression of pro-inflammatory cytokines such as IL-1ß. We report here that the development of hepatic steatosis requires IL-1 signaling, which upregulates Fatty acid synthase to promote hepatic lipogenesis. Using clodronate liposomes to selectively deplete liver Kupffer cells in ob/ob mice, we observed remarkable amelioration of obesity-induced hepatic steatosis and reductions in liver weight, triglyceride content and lipogenic enzyme expressions. Similar results were obtained with diet-induced obese mice, although visceral adipose tissue macrophage depletion also occurred in response to clodronate liposomes in this model. There were no differences in the food intake, whole body metabolic parameters, serum ß-hydroxybutyrate levels or lipid profiles due to clodronate-treatment, but hepatic cytokine gene expressions including IL-1ß were decreased. Conversely, treatment of primary mouse hepatocytes with IL-1ß significantly increased triglyceride accumulation and Fatty acid synthase expression. Furthermore, the administration of IL-1 receptor antagonist to obese mice markedly reduced obesity-induced steatosis and hepatic lipogenic gene expression. Collectively, our findings suggest that IL-1ß signaling upregulates hepatic lipogenesis in obesity, and is essential for the induction of pathogenic hepatic steatosis in obese mice.


Subject(s)
Fatty Liver/genetics , Interleukin-1beta/genetics , Lipogenesis/genetics , Obesity/metabolism , Animals , Fatty Acid Synthase, Type I/biosynthesis , Fatty Liver/etiology , Fatty Liver/metabolism , Fatty Liver/pathology , Gene Expression/drug effects , Hepatocytes/drug effects , Hepatocytes/metabolism , Humans , Interleukin-1beta/biosynthesis , Interleukin-1beta/metabolism , Kupffer Cells , Mice , Mice, Obese , Obesity/complications , Obesity/pathology , Receptors, Interleukin-1/antagonists & inhibitors , Signal Transduction/drug effects
2.
J Biol Chem ; 288(4): 2882-92, 2013 Jan 25.
Article in English | MEDLINE | ID: mdl-23235150

ABSTRACT

Inflammation induced by wound healing or infection activates local vascular endothelial cells to mediate leukocyte rolling, adhesion, and extravasation by up-regulation of leukocyte adhesion molecules such as E-selectin and P-selectin. Obesity-associated adipose tissue inflammation has been suggested to cause insulin resistance, but weight loss and lipolysis also promote adipose tissue immune responses. While leukocyte-endothelial interactions are required for obesity-induced inflammation of adipose tissue, it is not known whether lipolysis-induced inflammation requires activation of endothelial cells. Here, we show that ß(3)-adrenergic receptor stimulation by CL 316,243 promotes adipose tissue neutrophil infiltration in wild type and P-selectin-null mice but not in E-selectin-null mice. Increased expression of adipose tissue cytokines IL-1ß, CCL2, and TNF-α in response to CL 316,243 administration is also dependent upon E-selectin but not P-selectin. In contrast, fasting increases adipose-resident macrophages but not neutrophils, and does not activate adipose-resident endothelium. Thus, two models of lipolysis-induced inflammation induce distinct immune cell populations within adipose tissue and exhibit distinct dependences on endothelial activation. Importantly, our results indicate that ß(3)-adrenergic stimulation acts through up-regulation of E-selectin in adipose tissue endothelial cells to induce neutrophil infiltration.


Subject(s)
Adipose Tissue/pathology , E-Selectin/metabolism , Receptors, Adrenergic, beta-3/metabolism , Adipose Tissue/metabolism , Animals , Chemokine CCL2/metabolism , Diabetes Mellitus, Type 2/metabolism , Human Umbilical Vein Endothelial Cells , Humans , Immune System , Inflammation , Interleukin-1beta/metabolism , Lipolysis , Mice , Mice, Inbred C57BL , Mice, Knockout , Neutrophils/metabolism , Tumor Necrosis Factor-alpha/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...